NL-OMON29227
Completed
Not Applicable
Randomized, double blind, placebo controlled trial of intramyocardial injection of autologous bone marrow cells in no-option patients with refractory angina pectoris and documented ischemia.
Departmartement of Cardiology,Leiden University Medical Center ,Leiden, the Netherlands0 sites50 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Refractory angina pectoris and documented myocardial ischemia.
- Sponsor
- Departmartement of Cardiology,Leiden University Medical Center ,Leiden, the Netherlands
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
/A
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Severe refractory angina despite optimal medical therapy;
- •2\. Reversible ischemia on GATED\-SPECT;
Exclusion Criteria
- •1\. Acute myocardial infarction, PCI or CABG within 6 months of enrolment in the study;
- •2\. History of malignancy (except low grade and fully resolved non\-melanoma skin malignancy);
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Alfentanil in CT-colonography.PainCt-colonographyColorectal cancerPolypsNL-OMON25320Academic Medical Center90
Completed
Not Applicable
Efficacy and safety of ezetimibe in young children with familial hypercholesterolemia.Familial hypercholesterolemiaNL-OMON25426Academic Medical Centre (AMC), Department of Vascular Medicine70
Recruiting
Not Applicable
The FCATFibromyalgiaNL-OMON28585eiden University Medical Center (LUMC)40
Recruiting
Not Applicable
The LCAT studyow back painNL-OMON26947eiden University Medical Center (LUMC)40
Recruiting
Not Applicable
Magnesium oxide to reduce prostate motion.1. Prostate cancer<br />2. radiotherapy.<br />(NLD: prostaatkanker, bestraling).NL-OMON24191niversity Medical Center Utrecht, The Netherlands184